MI

Mallikarjun Ithli

Active Director Director DIN 09682299
DIN 09682299 First appointment Jul 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2022
Shareholding value •••• Premium profile

About Mallikarjun Ithli

Data last updated:

Mallikarjun Ithli is a Director at Samskruthy Pharma Private Limited (since 2022). The company operates in Pharma. Samskruthy Pharma Private Limited reported revenue of ₹6.82 Cr (FY 2025).

DIN 09682299
Primary Designation Director
Industry Pharma
First Appointment 22 Jul 2022
Oldest Company Age 9 yrs
Largest company Samskruthy Pharma Private Limited · ₹6.82 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Samskruthy Pharma Private Limited U51909KA2017PTC101764
Director22 Jul 20222017₹6.82 Cr (FY 2025)Active

Board colleagues of Mallikarjun Ithli

Directorship timeline

Open interactive timeline →
Samskruthy Pharma Private Limited
Premium access

Shareholding and investment profile for Mallikarjun Ithli

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mallikarjun Ithli

Mallikarjun Ithli currently holds 1 directorship: Samskruthy Pharma Private Limited (Director, since 22 Jul 2022, revenue ₹6.82 Cr (FY 2025)).

Mallikarjun Ithli was first appointed on 22 Jul 2022 as Director at Samskruthy Pharma Private Limited.

The current boards of Mallikarjun Ithli's companies include Channabasava Swamy Hiremath (Samskruthy Pharma Private Limited), Rajeev Bisati (Samskruthy Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available